Paper1975321
GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lancet, 1990. Cited by 213 papers, by iCite.
Cite this record
ConductScience Library. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Papers, record 1975321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1975321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparin | Major topic |
| Myocardial Infarction | Major topic |
| Streptokinase | Major topic |
| Thrombolytic Therapy | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Aged | |
| Aspirin | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Echocardiography | |
| Female | |
| Humans | |
| Male | |
| Multicenter Studies as Topic | |
| Randomized Controlled Trials as Topic | |
| Time Factors |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00149591 | The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial) | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 1974965 | GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction? | https://conductscience.org/library/papers/1974965 | PubMed |
| Comment in | 1975887 | Limitations of serum creatine kinase assay in diagnosis of acute myocardial infarction. | https://conductscience.org/library/papers/1975887 | PubMed |
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40429386 | Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. | J Clin Med | 2025 | https://conductscience.org/library/papers/40429386 | PubMed |
| 39600808 | Bleeding characteristics and mortality outcomes following ST-elevation myocardial infarction thrombolysis: a 5-year analysis in an Asian population. | World J Emerg Med | 2024 | https://conductscience.org/library/papers/39600808 | PubMed |
| 37750155 | A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries. | Cureus | 2023 | https://conductscience.org/library/papers/37750155 | PubMed |
| 36046799 | Vascular occlusion in a previously unaffected territory after treatment with intravenous plasminogen activator: illustrative case. | J Neurosurg Case Lessons | 2021 | https://conductscience.org/library/papers/36046799 | PubMed |
| 31531077 | Optimization and High Level Production of Recombinant Synthetic Streptokinase in E. coli Using Response Surface Methodology. | Iran J Pharm Res | 2019 | https://conductscience.org/library/papers/31531077 | PubMed |
| 31074337 | Embedding patient- and public health-oriented research in a national health service: the GISSI experience. | J R Soc Med | 2019 | https://conductscience.org/library/papers/31074337 | PubMed |
| 30627739 | [Therapy of cardiogenic shock : A success story of German cardiology]. | Herz | 2019 | https://conductscience.org/library/papers/30627739 | PubMed |
| 29581926 | Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review. | Cureus | 2018 | https://conductscience.org/library/papers/29581926 | PubMed |
| 29391934 | Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen. | J Cardiovasc Thorac Res | 2017 | https://conductscience.org/library/papers/29391934 | PubMed |
| 28894481 | Respiratory research networks in Europe and beyond: aims, achievements and aspirations for the 21st century. | Breathe (Sheff) | 2017 | https://conductscience.org/library/papers/28894481 | PubMed |
| 28769230 | THROMBOLYSIS IN MYOCARDIAL INFARCTION. | Med J Armed Forces India | 1995 | https://conductscience.org/library/papers/28769230 | PubMed |
| 28209124 | RNA-seq and metabolomic analyses of Akt1-mediated muscle growth reveals regulation of regenerative pathways and changes in the muscle secretome. | BMC Genomics | 2017 | https://conductscience.org/library/papers/28209124 | PubMed |
| 27904506 | Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials. | Arch Med Sci | 2016 | https://conductscience.org/library/papers/27904506 | PubMed |
| 27696935 | The evolution of recombinant thrombolytics: Current status and future directions. | Bioengineered | 2017 | https://conductscience.org/library/papers/27696935 | PubMed |
| 27326056 | Spontaneous recovery of complete atrioventricular block complicating acute anterior wall ST elevation myocardial infarction. | Heart Asia | 2012 | https://conductscience.org/library/papers/27326056 | PubMed |
| 25894475 | Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement. | J Thromb Thrombolysis | 2015 | https://conductscience.org/library/papers/25894475 | PubMed |
| 25746841 | The relationship between grade of ischemia, success of reperfusion, and type of thrombolytic regimen. | Med Sci Monit | 2015 | https://conductscience.org/library/papers/25746841 | PubMed |
| 24972265 | Heparin versus placebo for non-ST elevation acute coronary syndromes. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24972265 | PubMed |
| 24829715 | Fibrinolytic Therapy in CCU Instead of Emergency Ward: How It Affects Door to Needle Time? | Int J Prev Med | 2014 | https://conductscience.org/library/papers/24829715 | PubMed |
| 24653840 | Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review. | ISRN Cardiol | 2014 | https://conductscience.org/library/papers/24653840 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DNLZ | 728489 | PubTator's text mining | https://conductscience.org/library/genes/728489 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1975321
GET https://conductscience.org/api/papers/v1/1975321/cited_by?page=2